Showing results (131-140 of 220) with videos related to
Sort By:
Pageof 22
Science Signaling|November 24, 2016
A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemiaZhousheng Xiao, Demian Riccardi, Hector A Velazquez, et al.Annals of Internal Medicine|September 13, 2013
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort studyCsaba P Kovesdy, Anthony J Bleyer, Miklos Z Molnar, et al.Kidney International|November 5, 2015
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 productionValentin David, Aline Martin, Tamara Isakova, et al.Kidney International|July 23, 2022
Heparin, klotho, and FGF23: the 3-beat waltz of the discordant heartMarta Martinez-Calle, Valentin DavidThe Journal of Clinical Investigation|December 5, 2017
Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogenesisZhousheng Xiao, Jerome Baudry, Li Cao, et al.Diagnostics (Basel, Switzerland)|October 10, 2018
Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal DiseaseZhongji Han, Zhousheng Xiao, Kamyar Kalantar-Zadeh, et al.Kidney International|April 29, 2026
Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophyDominik Kentrup, Jane Joy Thomas, Guillaume Courbon, et al.Bioconjugate Chemistry|July 10, 2012
Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cellsErik C Dreaden, Berkley E Gryder, Lauren A Austin, et al.The Journal of Biological Chemistry|October 4, 2005
Identification of a novel extracellular cation-sensing G-protein-coupled receptorMin Pi, Pieter Faber, George Ekema, et al.Bone Research|May 3, 2019
DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney diseaseCorey Dussold, Claire Gerber, Samantha White, et al.Pageof 22